发明名称 Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment
摘要 The invention novel compounds, pharmaceutical compositions and methods useful for preventing or treating cancer in animals and humans. Also, the invention provides novel prodrugs useful for reducing tumor size, and inhibiting the growth of cancers, inhibiting tumor cell growth and tumor cell proliferation, and promoting apoptosis of tumor cells. When used in combination with chemoradiation therapy, the novel compounds, compositions and prodrugs provided herein can improve the effectiveness of chemoradiation therapy. The novel compounds, compositions and prodrugs of the invention inhibit PDK and LDH in unique and effective ways.
申请公布号 US9556113(B2) 申请公布日期 2017.01.31
申请号 US201514699946 申请日期 2015.04.29
申请人 The South Dakota Board of Regents;Sanford Research 发明人 Guan Xiangming;Dwivedi Chandrahar;Li Yinghong;Yang Yang;Lee John H.;Miskimins Wilson Keith
分类号 C07C235/74;A61K45/06;A61N5/10;A61K31/225;C07C233/56;A61K33/24;A61K9/00;A61K47/02;A61K47/10;A61K47/14;A61K47/18;A61K47/26;A61K9/06;A61K47/32;A61K9/08;A61K47/38;A61K47/44;A61K9/20;A61K9/48 主分类号 C07C235/74
代理机构 Billion & Armitage 代理人 Billion & Armitage ;Jurkovich Patti J.
主权项 1. A compound:wherein R1 and R2 are each dichloroacetate, and R3 is H, oxamate, —C(O)C(O)N(R4)(R5), dichloroacetate, or R*, wherein R* is a diacid, an amino acid, an alkyl group, an aryl group, a heterocyclic group, or a pharmaceutically acceptable salt thereof, wherein R4 and R5 are each independently a (C1-C20)alkyl group, a (C3-C16)cycloalkyl group, a (C6-C14)aryl group, furan, pyridine, imidazole, or a pharmaceutically acceptable salt thereof.
地址 Pierre SD US